Skip to Content

Bimatoprost Topical Dosage

Medically reviewed on May 7, 2018.

Applies to the following strengths: 0.03%

Usual Adult Dose for Hypotrichosis of the Eyelashes

Apply 1 drop to the upper eyelid margin of each eye once a day at night
-Additional drops or applications will not increase eyelash growth

-Apply topically to clean, makeup-free skin using the supplied sterile applicators; 1 applicator for each eye
-Place 1 drop of this drug on an applicator; apply evenly along the skin of the upper eyelid at base of lashes.
-Following administration, upper lid margin should feel lightly moist; if there is runoff, blot with a tissue or absorbent cloth.
-Repeat for the opposite eyelid margin using a new sterile applicator.

Comment: Eyelash growth is expected to return to pretreatment levels upon drug discontinuation.

Use: For the treatment of hypotrichosis of the eyelashes by increasing growth including length, thickness, and darkness.

Renal Dose Adjustments

No dosage adjustment is recommended.

Liver Dose Adjustments

No dosage adjustment is recommended.


Safety and efficacy have not been established in patients younger than 5 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:
-Apply once a day at night
-Prior to application, remove makeup and contact lenses, clean and dry face
-Place 1 drop on applicator and apply evenly along the skin of the upper eyelid at base of lashes
-Blot any runoff solution with a tissue or absorbent cloth
-Do not apply to lower eyelids
-Repeat dosing application to the opposite eyelid using a new applicator (1 drop per eye, each on a new applicator)
-Any solution that gets into the eye will not cause harm and should not be rinsed
-Use only the supplied single-use disposable applicators
-Avoid allowing bottle tip or sterile applicator to contact fingers or any other unintended surface to avoid contamination
-Discard disposable applicator after use

Storage requirements: Store at 2C to 25C (36F to 77F).

General: Onset of effect is gradual (significant at approximately 2 months). This drug's effects are not permanent.

Monitoring: Patients using concomitant prostaglandin analogs should be monitored for changes to intraocular pressure.

Patient advice:
-Additional drops or applications will not increase eyelash growth
-Drug may cause eyelid skin darkening that may be reversible after discontinuation
-Drug may increase brown pigmentation of the iris, which is likely to be permanent
-Patients should be instructed to avoid application to skin surrounding the treatment area as unexpected hair growth may occur in areas repeatedly exposed to this drug
-Seek physician's advice if a new ocular condition occurs (e.g., trauma, infection, surgery), or for any sudden decrease in vision
-Seek physician's advice if conjunctivitis or eyelid reaction occurs

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.